Thousands of NHS posts lie vacant

Thousands of NHS nursing and doctor posts lie vacant

By Dominic Hughes and Vanessa Clarke
BBC News
  • 29 February 2016
  • From the section Health

Nurses walking in a hospitalImage copyright
Science Photo Library

More than two-thirds of trusts and health boards in the UK are actively trying to recruit from abroad as they struggle to cope with a shortage of qualified staff, figures reveal.

Tens of thousands of NHS nursing and doctor posts are vacant.

The statistics, obtained by the BBC, show the scale of the NHS recruitment crisis.

'Hundreds' of young in old people's homes

‘Hundreds’ of young in old people’s homes

By Eleanor Bradford
BBC Scotland Health Correspondent
  • 29 February 2016
  • From the section Scotland

Romana

Image caption

Romana was placed in a care home after suffering a brain haemorrhage at 23

Younger people with neurological conditions are being cared for in old people’s homes, according to the charity Sue Ryder.

It said there is nowhere else for them to go because of a lack of specialist facilities.

The Scottish government said it wants people to be treated in their own homes or as close to home as possible.

Closely watched AstraZeneca cancer drug fails in mesothelioma


A closely watched AstraZeneca drug did not extend lives of patients with the rare cancer mesothelioma when given on its own, but the drugmaker said it still believed the medicine had a role to play in combination treatments.

Mesothelioma is a deadly form of cancer that affects the lining of the lungs or abdomen. Patients typically live only nine to 12 months after initial diagnosis.

In a clinical trial tremelimumab failed to meet the goal of improving overall survival in hard-to-treat mesothelioma patients whose disease had already been treated unsuccessfully with standard drugs, AstraZeneca said on Monday.

Swiss Basilea says profits still 2-3 years away


Swiss drugmaker Basilea expects to move into profit by 2018, counting on new anti-infection drugs to help mitigate setbacks such as last month’s collapse of efforts to win U.S. approval for an eczema treatment.

On Monday, Basilea reported a full-year 2015 net loss of 61.6 million Swiss francs ($60.9 million), bringing total losses since 2011 to nearly 250 million francs.

The Basel-based company, whose strategy hinges on winning partners to sell drugs it develops, could lose up to 60 million francs on an operating level this year, it said.

France says detects first sexually transmitted Zika case


France has detected its first sexually transmitted case of Zika in a woman whose partner had traveled to Brazil, the epicenter of an outbreak of the virus, a senior health official said on Saturday.

U.S. officials said earlier this week they were investigating 14 reports of the mosquito-borne disease that may have been transmitted through sex, including to several pregnant women.

Francois Bourdillon, head of France’s Institute for Public Health Surveillance (IVS), said the infected woman was the country’s “first confirmed indigenous case of transmission”.

France says detects first sexually transmitted Zika case


France has detected its first sexually transmitted case of Zika in a woman whose partner had traveled to Brazil, the epicenter of an outbreak of the virus, a senior health official said on Saturday.

U.S. officials said earlier this week they were investigating 14 reports of the mosquito-borne disease that may have been transmitted through sex, including to several pregnant women.

Francois Bourdillon, head of France’s Institute for Public Health Surveillance (IVS), said the infected woman was the country’s “first confirmed indigenous case of transmission”.

More tooth decay among English children

Tooth decay still on the rise among English children

By Dominic Howell
BBC News
  • 26 February 2016
  • From the section Health

tooth decayImage copyright
Thinkstock

The number of children in England having their teeth removed because of decay has increased for the fourth year in a row, new figures suggest.

In 2014-15 there were 33,781 cases of children, aged 10 and under, needing the removal of one or more teeth – a rise of 3% on the previous year.

The Chief Dental Officer for NHS England, Sara Hurley, described the figures as “disappointing”.

China says to speed up approvals for some drugs

Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015.  REUTERS/Aly Song
Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015.

Reuters/Aly Song


China’s drug regulator said it would accelerate approvals of new medicines, long a headache for pharmaceutical firms who complain it takes too long to get drugs to market.

The China Food and Drug Administration (CFDA) said in a statement published on Friday that it would prioritize the approval of drugs with clear clinical value, including those that use advanced technology or innovative methods.

China says to speed up approvals for some drugs

Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015.  REUTERS/Aly Song
Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015.

Reuters/Aly Song


China’s drug regulator said it would accelerate approvals of new medicines, long a headache for pharmaceutical firms who complain it takes too long to get drugs to market.

The China Food and Drug Administration (CFDA) said in a statement published on Friday that it would prioritize the approval of drugs with clear clinical value, including those that use advanced technology or innovative methods.

China says to speed up approvals for some drugs

Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015.  REUTERS/Aly Song
Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015.

Reuters/Aly Song


China’s drug regulator said it would accelerate approvals of new medicines, long a headache for pharmaceutical firms who complain it takes too long to get drugs to market.

The China Food and Drug Administration (CFDA) said in a statement published on Friday that it would prioritize the approval of drugs with clear clinical value, including those that use advanced technology or innovative methods.